| | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
---|
|
| | | IPat | | Gemmo Gelenkbeschwerden | 30 ml | DDP | DDP | N.O. | | Spray zur Anwendung in der Mundhöhle: 3 Principes actifs | Spagyros AG | D | FB | | G |  |
|
L | | IPro | IPat | PP | Spinraza 12mg/5ml | 5 ml | 78390.18 | 80736.10 | 10% | | Lösung zur intrathekalen Injektion: Nusinersenum 12mg / 5ml | Biogen Switzerland AG | A / LS | FB | | G |  |
|
| | IPro | IPat | | ZOLGENSMA | 3 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 3 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 2 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 4 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 4 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 3 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 5 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 5 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 6 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 6 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 4 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 7 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 7 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 5 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 8 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 8 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 9 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 9 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 6 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 10 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 10 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 7 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 11 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 11 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 8 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 9 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IPro | IPat | | ZOLGENSMA | 10 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma Schweiz AG | A | FB | | G |  |
|
L | | IPro | IPat | | Evrysdi 0.75 mg/ml | 80 ml | 7956.67 | 8471.35 | 10% | | Pulver zur Herstellung einer Lösung zum Einnehmen: Risdiplamum 60 mg | Roche Pharma (Schweiz) AG | A / LS | FB | | G |  |